Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Sanara MedTech (SMTI) EBT Margin (2016 - 2025)

Sanara MedTech (SMTI) has disclosed EBT Margin for 15 consecutive years, with 24.89% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, EBT Margin rose 2558.0% year-over-year to 24.89%, compared with a TTM value of 0.33% through Sep 2025, up 703.0%, and an annual FY2024 reading of 11.33%, down 450.0% over the prior year.
  • EBT Margin was 24.89% for Q3 2025 at Sanara MedTech, up from 7.06% in the prior quarter.
  • Across five years, EBT Margin topped out at 24.89% in Q3 2025 and bottomed at 48.52% in Q4 2021.
  • Average EBT Margin over 5 years is 15.95%, with a median of 14.48% recorded in 2025.
  • The sharpest move saw EBT Margin plummeted -3071bps in 2021, then skyrocketed 2771bps in 2023.
  • Year by year, EBT Margin stood at 48.52% in 2021, then skyrocketed by 44bps to 27.18% in 2022, then surged by 95bps to 1.48% in 2023, then crashed by -326bps to 6.33% in 2024, then surged by 493bps to 24.89% in 2025.
  • Business Quant data shows EBT Margin for SMTI at 24.89% in Q3 2025, 7.06% in Q2 2025, and 14.48% in Q1 2025.